ArticleInvestigational new drugs2021

Pancreatic cancer drug-sensitivity predicted by synergy of p53-Activator Wnt Inhibitor-2 (PAWI-2) and protein biomarker expression.

Jiongjia Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.